A method for estimating the probability of adverse drug reactions CA Naranjo, U Busto, EM Sellers, P Sandor, I Ruiz, EA Roberts, ... Clinical Pharmacology & Therapeutics 30 (2), 239-245, 1981 | 12606 | 1981 |
Midazolam: pharmacology and uses. JG Reves, RJ Fragen, HR Vinik, DJ Greenblatt Anesthesiology 62 (3), 310-324, 1985 | 1346 | 1985 |
Effect of obesity on the pharmacokinetics of drugs in humans MJ Hanley, DR Abernethy, DJ Greenblatt Clinical pharmacokinetics 49, 71-87, 2010 | 847 | 2010 |
Drug disposition in old age DJ Greenblatt, EM Sellers, RI Shader New England Journal of Medicine 306 (18), 1081-1088, 1982 | 816 | 1982 |
Effect of age, gender, and obesity on midazolam kinetics. DJ Greenblatt, DR Abernethy, A Locniskar, JS Harmatz, RA Limjuco, ... Anesthesiology 61 (1), 27-35, 1984 | 704 | 1984 |
Clinical Pharmacokinetics: (First of Two Parts) DJ Greenblatt, J Koch-Weser New England Journal of Medicine 293 (14), 702-705, 1975 | 680* | 1975 |
Effects of the antifungal agents on oxidative drug metabolism: clinical relevance K Venkatakrishnan, LL Von Moltke, DJ Greenblatt Clinical pharmacokinetics 38, 111-180, 2000 | 671 | 2000 |
Use of benzodiazepines in anxiety disorders RI Shader, DJ Greenblatt New England Journal of Medicine 328 (19), 1398-1405, 1993 | 511 | 1993 |
Drug therapy: Current status of benzodiazepines: I. DJ Greenblatt, RI Shader, DR Abernethy The New England Journal of Medicine, 1983 | 501 | 1983 |
Dose‐dependent pharmacokinetics and psychomotor effects of caffeine in humans GB Kaplan, DJ Greenblatt, BL Ehrenberg, JE Goddard, MM Cotreau, ... The Journal of Clinical Pharmacology 37 (8), 693-703, 1997 | 466 | 1997 |
Long-term therapeutic use of benzodiazepines: I. Effects of abrupt discontinuation K Rickels, E Schweizer, WG Case, DJ Greenblatt Archives of General Psychiatry 47 (10), 899-907, 1990 | 459 | 1990 |
Benzodiazepine overdosage: plasma concentrations and clinical outcome M Divoll, DJ Greenblatt, Y Lacasse, RI Shader Psychopharmacology 73, 381-383, 1981 | 456 | 1981 |
Human drug metabolism and the cytochromes P450: application and relevance of in vitro models K Venkatakrishnan, LL von Moltke, DJ Greenblatt The Journal of Clinical Pharmacology 41 (11), 1149-1179, 2001 | 437 | 2001 |
Diazepam disposition determinants DJ Greenblatt, MD Allen, JS Harmatz, RI Shader Clinical Pharmacology & Therapeutics 27 (3), 301-312, 1980 | 423 | 1980 |
The influence of age and sex on the clearance of cytochrome P450 3A substrates MM Cotreau, LL von Moltke, DJ Greenblatt Clinical pharmacokinetics 44, 33-60, 2005 | 419 | 2005 |
Propranolol interactions with diazepam, lorazepam, and alprazolam HR Ochs, DJ Greenblatt, B Verburg‐Ochs Clinical Pharmacology & Therapeutics 36 (4), 451-455, 1984 | 416 | 1984 |
Interaction of warfarin with drugs, natural substances, and foods DJ Greenblatt, LL von Moltke The Journal of Clinical Pharmacology 45 (2), 127-132, 2005 | 394 | 2005 |
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants LM Hesse, K Venkatakrishnan, LL von Moltke, SX Duan, RI Shader, ... Drug metabolism and disposition 28 (10), 1176-1183, 2000 | 384 | 2000 |
Vancomycin therapy in patients with impaired renal function: a nomogram for dosage RC MOELLERING Jr, DJ KROGSTAD, DJ GREENBLATT Annals of Internal Medicine 94 (3), 343-346, 1981 | 360 | 1981 |
Toxicity of high‐dose flurazepam in the elderly DJ Greenblatt, MD Allen, RI Shader Clinical Pharmacology & Therapeutics 21 (3), 355-361, 1977 | 341 | 1977 |